IDRA - Idera Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue90216,199249
Cost of Revenue---
Gross Profit90216,199249
Operating Expenses
Research Development50,65339,82433,699
Selling General and Administrative16,71615,13215,396
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-66,467-38,757-48,846
Income from Continuing Operations
Total Other Income/Expenses Net533448396
Earnings Before Interest and Taxes-65,934-38,309-48,450
Interest Expense5080105
Income Before Tax-65,984-38,389-48,555
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-65,984-38,389-48,555
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-65,984-38,389-48,555
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-65,984-38,389-48,555